Overview

Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Status:
Completed
Trial end date:
2012-08-31
Target enrollment:
Participant gender:
Summary
The study is a randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy.
Phase:
Phase 2
Details
Lead Sponsor:
Biogen
Convergence Pharmaceuticals